Anti-VEGF Drug Reverses Diabetic Vision Loss
(MedPage Today) -- Patients headed toward blindness because of diabetic macular edema showed substantial gains in visual acuity after two years of treatment with the angiogenesis inhibitor drug ranibizumab (Lucentis), its manufacturer said.